Jw Life Science Corp (234080.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7234080000
Jw Life Science Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 222.48 bn KRW | 257.83 bn KRW |
| Gross profit | 57.51 bn KRW | 72.32 bn KRW |
| Operating income | 35.86 bn KRW | 33.24 bn KRW |
| EBIT | 61.09 bn KRW | 34.58 bn KRW |
| Net income | 43.99 bn KRW | 28.61 bn KRW |
| Diluted EPS – continuing operations | 2,840.74 KRW | 1,847.38 KRW |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Jw Life Science Corp
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
More stocks
- BG Container Glass Public Company Limited (BGC.BK)
- Bancroft Fund Limited (BCV)
- UNITED BANCSHARES INC/OH (UBOH)
- Moller Y Perez (MOLLER.SN)
- Namyang Dairy Products Co Ltd Peffered Series 1 (003925.KS)
- e-Credible Co. Ltd (092130.KQ)
- EI Power Berhad (0453.KL)
- SPRUCE BIOSCIENCES, INC. (SPRB)
- EASY BIOInc (353810.KQ)
- Excelliance MOS (5299.TWO)
- Helixmith Co. Ltd (084990.KQ)
- Foghorn Therapeutics Inc. (FHTX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.